Active Pharmaceutical Ingredients Market Demand Rising at a CAGR of 7.98% to Reach USD 512.13 Billion from 2022 to 2030
Research Reports
Apr 18, 2023
Active Pharmaceutical Ingredients Market Research Report Information By Manufacturing Process (Captive Manufacturing and Contract Manufacturing), By Type of Synthesis (Synthetic and Biotech), By API Formulation (Generic API and Branded/Innovative API), By Application (Cardiovascular Disease, Oncology, Neurological Disorders, Orthopedic Disorders, Respiratory, Gastrointestinal Disorders, Urology, and others), By Molecules (Large Molecule and Small Molecule), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market 2030
The active pharmaceutical ingredients (API) market refers to the production, sale, and distribution of the chemical compounds that are used in the formulation of various pharmaceutical drugs. APIs are the core components of any medication, as they are responsible for the therapeutic effects of the drug. The global API market is expected to continue growing due to the increasing demand for generic drugs, biologics, and the rising prevalence of chronic diseases worldwide.
The global active pharmaceutical ingredients (API) market has been growing steadily over the past few years and is expected to continue to do so in the coming years. The global API market size was valued at USD 299.21 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.98% and is projected to reach value of USD 512.13 billion from 2022 to 2030.
Key Players
Some of the key players in the global active pharmaceutical ingredients (API) market include Pfizer Inc., Novartis International AG, Sanofi, Boehringer Ingelheim, Teva Pharmaceutical Industries Ltd., Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Bristol-Myers Squibb, Merck & Co., Inc., and AbbVie Inc., among others.
Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/1385
Market Segmentation
The global active pharmaceutical ingredients (API) market can be segmented on the basis of manufacturing process, type of synthesis, type of drug, therapeutic area, and region. Here is a brief overview of each segment:
Manufacturing Process: The API market can be segmented by manufacturing process into synthetic and biotech. Synthetic manufacturing involves the chemical synthesis of the API, while biotech manufacturing involves the use of living cells to produce the API.
Type of Synthesis: The API market can also be segmented by type of synthesis into innovative and generic. Innovative APIs are those that are newly developed, while generic APIs are those that have been previously developed and are available in the market.
Type of Drug: The API market can be segmented by type of drug into prescription drugs and over-the-counter (OTC) drugs. Prescription drugs are those that require a prescription from a healthcare provider, while OTC drugs are those that can be purchased without a prescription.
Therapeutic Area: The API market can be segmented by therapeutic area into cardiovascular, oncology, CNS and neurology, endocrinology, respiratory, gastrointestinal, and others.
Region: The API market can be segmented by region into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
These segments allow for a more detailed understanding of the active pharmaceutical ingredients market and can help businesses make informed decisions about where to invest their resources.
Regional Analysis
The active pharmaceutical ingredients (API) market is a global industry, with production and consumption occurring in various regions around the world. Here is a regional analysis of the API market:
North America: The North American API market is the largest in the world, driven by the presence of major pharmaceutical companies, a well-established healthcare infrastructure, and high demand for generic drugs. The United States is the largest market in the region, accounting for the majority of API consumption.
Europe: Europe is the second-largest API market globally, driven by the presence of leading pharmaceutical companies, a strong regulatory framework, and increasing demand for generic drugs. The United Kingdom, Germany, and France are the largest markets in the region.
Browse In-depth Market Research Report (157 Pages) on Active Pharmaceutical Ingredients:
https://www.marketresearchfuture.com/reports/active-pharmaceutical-ingredients-market-1385
Asia Pacific: The API market in Asia Pacific is growing rapidly, driven by the increasing demand for generic drugs and the presence of a large population base. India and China are the largest API manufacturers in the region, accounting for a significant portion of the global API production.
Latin America: The API market in Latin America is driven by increasing demand for generic drugs, a growing population base, and improving healthcare infrastructure. Brazil and Mexico are the largest markets in the region.
Middle East and Africa: The API market in the Middle East and Africa is growing, driven by increasing investment in healthcare infrastructure and rising demand for generic drugs. South Africa and Saudi Arabia are the largest markets in the region.
Overall, the global API market is expected to continue growing due to the increasing demand for generic drugs and biologics, as well as the rising prevalence of chronic diseases worldwide.
Discover More Research Reports on Healthcare Industry by Market Research Future:
Pharmaceutical Analytical Testing Outsourcing Market Research Report Information By Product (Finished Products and Active Pharmaceutical Ingredients), By Services (Bioanalytical Testing, Stability Testing, Method Development & Validation and others), By End-User (Biopharmaceutical Companies, Biotechnology Industry and Pharmaceutical), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030
Organ-on-a-chip Market Research Report By Organ Type (Lung-on-Chip, Heart-on-Chip, Liver-on-Chip, Intestine-on-Chip, Kidney-on-Chip, Human-on-Chip), By Application (Drug Discovery, Toxicology Research, Others) and By End-User (Pharmaceutical Companies, Research Organizations, Others) – Forecast to 2030
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Follow Us: LinkedIn | Twitter
Contact:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com
Contact Information:
Market Research Future (Part of Wantstats Research and Media Private Limited) 99 Hudson Street, 5Th Floor New York, NY 10013 United States of America +1 628 258 0071 (US) +44 2035 002 764 (UK) Email: sales@marketresearchfuture.com Website: https://www.marketresearchfuture.com
Tags:
Wire, Research Newswire, English